About the Authors
- Kayoko Waki
-
Affiliation Virus-Cell Interaction Section, HIV Drug Resistance Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
- Stewart R. Durell
-
Affiliation Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
- Ferri Soheilian
-
Affiliation Electron Microscope Laboratory, Advanced Technology Program, SAIC-Frederick, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
- Kunio Nagashima
-
Affiliation Electron Microscope Laboratory, Advanced Technology Program, SAIC-Frederick, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
- Scott L. Butler
-
Current address: Infection Innovative Medicine, AstraZeneca Pharmaceuticals, Waltham, Massachusetts, United States of America
Affiliation Antiviral Biology, Pfizer Global Research & Development, Sandwich Laboratories, Sandwich, Kent, United Kingdom
- Eric O. Freed
-
* E-mail: efreed@nih.gov
Affiliation Virus-Cell Interaction Section, HIV Drug Resistance Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
Competing Interests
I have read the journal's policy and have the following conflicts: One of the authors (Scott Butler) is a former employee of Pfizer. This does not alter our adherence to all PLoS Pathogens policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: KW SLB EOF. Performed the experiments: KW FS KN. Analyzed the data: KW SRD FS KN SLB EOF. Contributed reagents/materials/analysis tools: SRD SLB. Wrote the paper: KW EOF.